Literature DB >> 16798670

Lack of association of herpesviruses with brain tumors.

S Poltermann1, B Schlehofer, K Steindorf, P Schnitzler, K Geletneky, J R Schlehofer.   

Abstract

Gliomas are the most frequent primary brain tumors in humans. Many studies have been carried out on their etiology; however, the only confirmed risk factors are hereditary predisposing conditions and high dose of ionizing radiation. Recently, human cytomegalovirus (HCMV) gene products and nucleic acids were reported to be present in all of 27 glioma samples investigated in contrast to other brain tissues, and it was hypothesized that HCMV might play a role in glioma pathogenesis. To evaluate these findings, samples of 40 gliomas, 31 meningiomas, and 6 acoustic neurinomas (ACNs) were analyzed for the presence of HCMV macromolecules using polymerase chain reaction (PCR) and immunohistochemistry. Additionally, corresponding blood samples from 72 patients were analyzed for the presence of HCMV DNA to check for a possible contamination of tumor tissues with HCMV-infected blood cells. No HCMV DNA sequences were found, neither in brain tumor tissues nor in corresponding blood samples. Immunohistochemistry did not detect HCMV-specific proteins. Addressing a possible role of other herpesviruses as has been suggested in seroepidemiological studies, seroprevalence of antibodies to HCMV, herpes simplex virus (HSV), Epstein-Barr virus (EBV), and varicella-zoster virus (VZV) were determined by enzyme-linked immunosorbent assay (ELISA). Serological analyses of brain tumor patients showed no significant differences in the prevalences of antibodies to HCMV, HSV, EBV, or VZV compared to the general population. Thus, the data of the present study do not support the hypothesis of an association of herpesviruses with the development of primary brain tumors.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16798670     DOI: 10.1080/13550280600654573

Source DB:  PubMed          Journal:  J Neurovirol        ISSN: 1355-0284            Impact factor:   2.643


  41 in total

Review 1.  Role of tumor cell immune escape mechanisms in cytomegalovirus-mediated oncomodulation.

Authors:  Jindrich Cinatl; Martin Scholz; Hans Wilhelm Doerr
Journal:  Med Res Rev       Date:  2005-03       Impact factor: 12.944

2.  Prevalence of antibodies to four herpesviruses among adults with glioma and controls.

Authors:  M Wrensch; A Weinberg; J Wiencke; R Miike; G Barger; K Kelsey
Journal:  Am J Epidemiol       Date:  2001-07-15       Impact factor: 4.897

Review 3.  Human cytomegalovirus and human herpesvirus 6 genes that transform and transactivate.

Authors:  J Doniger; S Muralidhar; L J Rosenthal
Journal:  Clin Microbiol Rev       Date:  1999-07       Impact factor: 26.132

4.  Seroprevalence of herpes simplex virus types 1 and type 2 in the Frankfurt am Main area, Germany.

Authors:  H F Rabenau; S Buxbaum; W Preiser; B Weber; H W Doerr
Journal:  Med Microbiol Immunol       Date:  2002-03       Impact factor: 3.402

5.  Seroprevalence of varicella-zoster virus in the German population.

Authors:  P Wutzler; I Färber; S Wagenpfeil; H Bisanz; A Tischer
Journal:  Vaccine       Date:  2001-10-12       Impact factor: 3.641

6.  Specific localisation of human cytomegalovirus nucleic acids and proteins in human colorectal cancer.

Authors:  Lualhati Harkins; Andrea L Volk; Minu Samanta; Ivan Mikolaenko; William J Britt; Kirby I Bland; Charles S Cobbs
Journal:  Lancet       Date:  2002-11-16       Impact factor: 79.321

7.  Serum antibodies to JC virus, BK virus, simian virus 40, and the risk of incident adult astrocytic brain tumors.

Authors:  Dana E M Rollison; Kathy J Helzlsouer; Anthony J Alberg; Sandra Hoffman; Jean Hou; Richard Daniel; Keerti V Shah; Eugene O Major
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2003-05       Impact factor: 4.254

Review 8.  Immunomodulation by cytomegaloviruses: manipulative strategies beyond evasion.

Authors:  Edward S Mocarski
Journal:  Trends Microbiol       Date:  2002-07       Impact factor: 17.079

9.  Does prior infection with varicella-zoster virus influence risk of adult glioma?

Authors:  M Wrensch; A Weinberg; J Wiencke; H Masters; R Miike; G Barger; M Lee
Journal:  Am J Epidemiol       Date:  1997-04-01       Impact factor: 4.897

10.  Human cytomegalovirus in neoplastic cells of Epstein-Barr virus negative Hodgkin's disease.

Authors:  Gaosheng Huang; Qingguo Yan; Zhe Wang; Xiequn Chen; Xiaohui Zhang; Ying Guo; Jian Jian Li
Journal:  Int J Oncol       Date:  2002-07       Impact factor: 5.650

View more
  44 in total

1.  Cytomegalovirus infection enhances the immune response to influenza.

Authors:  David Furman; Vladimir Jojic; Shalini Sharma; Shai S Shen-Orr; Cesar J L Angel; Suna Onengut-Gumuscu; Brian A Kidd; Holden T Maecker; Patrick Concannon; Cornelia L Dekker; Paul G Thomas; Mark M Davis
Journal:  Sci Transl Med       Date:  2015-04-01       Impact factor: 17.956

Review 2.  Is HCMV a tumor promoter?

Authors:  Liliana Soroceanu; Charles S Cobbs
Journal:  Virus Res       Date:  2010-10-29       Impact factor: 3.303

3.  Consensus on the role of human cytomegalovirus in glioblastoma.

Authors:  Kristine Dziurzynski; Susan M Chang; Amy B Heimberger; Robert F Kalejta; Stuart R McGregor Dallas; Martine Smit; Liliana Soroceanu; Charles S Cobbs
Journal:  Neuro Oncol       Date:  2012-02-08       Impact factor: 12.300

4.  RE: "Lack of association of herpesviruses with brain tumors".

Authors:  Michael E Scheurer; Randa El-Zein; Melissa L Bondy; Lualhati Harkins; Charles S Cobbs
Journal:  J Neurovirol       Date:  2007       Impact factor: 2.643

Review 5.  Oncomodulation by human cytomegalovirus: evidence becomes stronger.

Authors:  Martin Michaelis; Hans Wilhelm Doerr; Jindrich Cinatl
Journal:  Med Microbiol Immunol       Date:  2009-02-07       Impact factor: 3.402

6.  Response to "Human cytomegalovirus infection in tumor cells of the nervous system is not detectable with standardized pathologico-virological diagnostics".

Authors:  Charles Cobbs
Journal:  Neuro Oncol       Date:  2014-10-13       Impact factor: 12.300

7.  Profiling of microRNAs modulating cytomegalovirus infection in astrocytoma patients.

Authors:  Ravindra Pramod Deshpande; Manas Panigrahi; Chandrasekhar Y B V K; Phanithi Prakash Babu
Journal:  Neurol Sci       Date:  2018-08-08       Impact factor: 3.307

8.  Sensitive detection of human cytomegalovirus in tumors and peripheral blood of patients diagnosed with glioblastoma.

Authors:  Duane A Mitchell; Weihua Xie; Robert Schmittling; Chris Learn; Allan Friedman; Roger E McLendon; John H Sampson
Journal:  Neuro Oncol       Date:  2007-10-19       Impact factor: 12.300

Review 9.  Chronic viral infection and primary central nervous system malignancy.

Authors:  Robert Saddawi-Konefka; John R Crawford
Journal:  J Neuroimmune Pharmacol       Date:  2010-04-13       Impact factor: 4.147

10.  Detection of human cytomegalovirus in different histological types of gliomas.

Authors:  Michael E Scheurer; Melissa L Bondy; Kenneth D Aldape; Thomas Albrecht; Randa El-Zein
Journal:  Acta Neuropathol       Date:  2008-03-20       Impact factor: 17.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.